Ultrastructural study of degradation of calcium phosphate ceramic by human monocytes and modulation of this activity by HILDA/LIF cytokine

被引:21
作者
Benahmed, MD
Heymann, D
Berreur, M
Cottrel, M
Godard, A
Daculsi, G
Pradal, G
机构
[1] FAC MED,LAB HISTOL & EMBRYOL,REIMS,FRANCE
[2] INST BIOL,REIMS,FRANCE
[3] CTR REG MICROSCOPIE ELECT & MICROANAL LENSEMBLE S,REIMS,FRANCE
关键词
biphasic calcium phosphate ceramic; monocytes; HILDA/LIF; cytokines; cytotic phenomena; cell-crystal interaction; transmission electron microscopy;
D O I
10.1177/44.10.8813078
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Biodegradation of ceramics in vivo is achieved essentially by monocytes and multinuclear cells (osteoclasts). Monocytes are the key element in this process because they intervene first at the biomaterial implantation site during inflammatory reaction. In this work, in vitro studies were conducted on an ultrastructural scale to determine the specific behavior of these cells with regard to a calcium phosphate (CaP) ceramic. Two types of phagocytosis were observed when cells came into contact with the biomaterial: either CaP crystals were taken up alone and then dissolved in the cytoplasm after disappearance of the phagosome membrane or they were incorporated together with large quantities of culture medium, in which case dissolution occurred after the formation of heterophagosomes. Phagocytosis of CaP coincided with autophagy and the accumulation of residual bodies in the cells. Addition of HILDA/LIF factor to these cultures induced a very marked decrease in phagocytotic activity directed at the capture of CaP crystals and culture medium. Autophagy was reduced, and residual bodies were rare or absent. This study specifies the role of monocytes in CaP biodegradation and demonstrates for the first time that HILDA/LIF has a biological effect on this cell line.
引用
收藏
页码:1131 / 1140
页数:10
相关论文
共 32 条
[21]  
MOREAU JF, 1987, J IMMUNOL, V138, P3844
[22]   CAPACITY OF ALLOREACTIVE HUMAN T-CLONES TO PRODUCE FACTOR(S) INDUCING PROLIFERATION OF THE IL3-DEPENDENT DA-1 MURINE CELL-LINE .1. EVIDENCE THAT THIS PRODUCTION IS UNDER IL2 CONTROL [J].
MOREAU, JF ;
BONNEVILLE, M ;
PEYRAT, MA ;
JACQUES, Y ;
SOULILLOU, JP .
ANNALES DE L INSTITUT PASTEUR-IMMUNOLOGY, 1986, C137 (01) :25-37
[23]   LEUKEMIA INHIBITORY FACTOR IS IDENTICAL TO THE MYELOID GROWTH-FACTOR HUMAN INTERLEUKIN FOR DA CELLS [J].
MOREAU, JF ;
DONALDSON, DD ;
BENNETT, F ;
WITEKGIANNOTTI, J ;
CLARK, SC ;
WONG, GG .
NATURE, 1988, 336 (6200) :690-692
[24]  
PASSUTI N, 1989, CLIN ORTHOP RELAT R, V248, P169
[25]  
Pitt D, 1975, LYSOSOMES CELL FUNCT
[26]   LEUKEMIA INHIBITORY FACTOR - A NOVEL BONE-ACTIVE CYTOKINE [J].
REID, IR ;
LOWE, C ;
CORNISH, J ;
SKINNER, SJM ;
HILTON, DJ ;
WILLSON, TA ;
GEARING, DP ;
MARTIN, TJ .
ENDOCRINOLOGY, 1990, 126 (03) :1416-1420
[27]  
ROODMAN CD, 1993, CALCIFIED TISSUE INT, V53, P594
[28]   INHIBITION OF PLURIPOTENTIAL EMBRYONIC STEM-CELL DIFFERENTIATION BY PURIFIED POLYPEPTIDES [J].
SMITH, AG ;
HEATH, JK ;
DONALDSON, DD ;
WONG, GG ;
MOREAU, J ;
STAHL, M ;
ROGERS, D .
NATURE, 1988, 336 (6200) :688-690
[29]  
SOUEIDAN A, 1995, CELL MATER, V5, P31
[30]  
TOMIDA M, 1984, J BIOL CHEM, V259, P978